These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 17664310)

  • 1. Assessing research risks systematically: the net risks test.
    Wendler D; Miller FG
    J Med Ethics; 2007 Aug; 33(8):481-6. PubMed ID: 17664310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refuting the net risks test: a response to Wendler and Miller's "Assessing research risks systematically".
    Weijer C; Miller PB
    J Med Ethics; 2007 Aug; 33(8):487-90. PubMed ID: 17664311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imagination and attention: protecting participants in psychopharmacological research.
    Koski G
    Psychopharmacology (Berl); 2003 Dec; 171(1):56-7. PubMed ID: 14598015
    [No Abstract]   [Full Text] [Related]  

  • 4. When "minimal risk" research yields clinically-significant data, maybe the risks aren't so minimal.
    Sharp HM; Orr RD
    Am J Bioeth; 2004; 4(2):W32-6. PubMed ID: 15186687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is risky pediatric research without prospect of direct benefit ever justified?
    Martin RA; Robert JS
    Am J Bioeth; 2007 Mar; 7(3):12-5. PubMed ID: 17366221
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical research with healthy volunteers: an ethical framework.
    Miller FG
    J Investig Med; 2003 Feb; 51 Suppl 1():S2-5. PubMed ID: 12664947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research ethics.
    Aarons D
    West Indian Med J; 1995 Dec; 44(4):115-8. PubMed ID: 8838046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eschewing definitions of the therapeutic misconception: a family resemblance analysis.
    Goldberg DS
    J Med Philos; 2011 Jun; 36(3):296-320. PubMed ID: 21606116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of the research ethics committees in Thailand.
    Panichkul S; Mahaisavariya P; Morakote N; Condo S; Caengow S; Ketunpanya A
    J Med Assoc Thai; 2011 Aug; 94(8):1013-8. PubMed ID: 21863687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Third-party risks in research: should IRBs address them?
    Hausman DM
    IRB; 2007; 29(3):1-5. PubMed ID: 17847635
    [No Abstract]   [Full Text] [Related]  

  • 11. Estimating risks and benefits in AIDS vaccine and drug trials.
    Kessel E
    AIDS Public Policy J; 1990; 5(4):186-8. PubMed ID: 11650977
    [No Abstract]   [Full Text] [Related]  

  • 12. Protecting subjects who cannot give consent: toward a better standard for "minimal" risks.
    Wendler D
    Hastings Cent Rep; 2005; 35(5):37-43. PubMed ID: 16295263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demarcating research and treatment: a systematic approach for the analysis of the ethics of clinical research.
    Freedman B; Fuks A; Weijer C
    Clin Res; 1992 Dec; 40(4):653-60. PubMed ID: 1486732
    [No Abstract]   [Full Text] [Related]  

  • 14. Twenty-five years of therapeutic misconception.
    Miller FG
    Hastings Cent Rep; 2008; 38(2):6; author reply 6-7. PubMed ID: 18457218
    [No Abstract]   [Full Text] [Related]  

  • 15. Undue inducements and reasonable risks: will the dismal science lead to dismal research ethics?
    London AJ
    Am J Bioeth; 2005; 5(5):29-32. PubMed ID: 16179305
    [No Abstract]   [Full Text] [Related]  

  • 16. Ethical issues related to clinical pharmacy research. American College of Clinical Pharmacy.
    Pharmacotherapy; 1993; 13(5):523-30. PubMed ID: 8247927
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug development: assessment of pharmacogenetic studies by Spanish research ethics committees.
    Dal-Ré R; Luque I; Torres R; Lahuerta J
    Pharmacogenomics J; 2009 Apr; 9(2):86-9. PubMed ID: 19079365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hidden risks associated with clinical trials in developing countries.
    Lorenzo C; Garrafa V; Solbakk JH; Vidal S
    J Med Ethics; 2010 Feb; 36(2):111-5. PubMed ID: 20133407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The IRB's role in assessing the generalizability of non-NIH-funded clinical trials.
    Weijer C
    IRB; 1998; 20(2-3):1-5. PubMed ID: 11656912
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessing benefits in clinical research: why diversity in benefit assessment can be risky.
    Churchill LR; Nelson DK; Henderson GE; King NM; Davis AM; Leahey E; Wilfond BS
    IRB; 2003; 25(3):1-8. PubMed ID: 14569987
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.